iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/16307201/
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Feb;253(2):224-30.
doi: 10.1007/s00415-005-0964-z. Epub 2005 Nov 24.

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study

M Tiberio  1 , D T Chard, D R Altmann, G Davies, C M Griffin, M A McLean, W Rashid, J Sastre-Garriga, A J Thompson, D H Miller
Affiliations
Comparative Study

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study

M Tiberio et al. J Neurol. 2006 Feb.

Abstract

Previous in vivo proton magnetic resonance spectroscopic imaging ((1)H-MRSI) studies have found reduced levels of N-acetyl-aspartate (NAA) in multiple sclerosis (MS) lesions, the surrounding normal-appearing white matter (NAWM) and cortical grey matter (CGM), suggesting neuronal and axonal dysfunction and loss. Other metabolites, such as myoinositol (Ins), creatine (Cr), choline (Cho), and glutamate plus glutamine (Glx), can also be quantified by (1)H-MRSI, and studies have indicated that concentrations of these metabolites may also be altered in MS. Relatively little is known about the time course of such metabolite changes. This preliminary study aimed to characterise changes in total NAA (tNAA, the sum of NAA and N-acetyl-aspartyl-glutamate), Cr, Cho, Ins and Glx concentrations in NAWM and in CGM, and their relationship with clinical outcome, in subjects with clinically early relapsing-remitting MS (RRMS). Twenty RRMS subjects and 10 healthy control subjects underwent (1)H-MRSI examinations yearly for two years. Using the LCModel, tNAA, Cr, Cho, Ins and Glx concentrations were estimated both in NAWM and CGM. At baseline, the concentration of tNAA was significantly reduced in the NAWM of the MS patients compared to the control group (-7%, p = 0.003), as well as in the CGM (-8.7%, p = 0.009). NAWM tNAA concentrations tended to recover from baseline, but otherwise tissue metabolite profiles did not significantly change in the MS subjects, or relatively between MS and healthy control subjects. While neuronal and axonal damage is apparent from the early clinical stages of MS, this study suggests that initially it may be partly reversible. Compared with other MR imaging measures, serial (1)H-MRSI may be relatively less sensitive to progressive pathological tissue changes in early RRMS.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arch Neurol. 2005 Apr;62(4):569-73 - PubMed
    1. Brain. 2004 May;127(Pt 5):1101-7 - PubMed
    1. Magn Reson Imaging. 1996;14(5):495-505 - PubMed
    1. Arch Neurol. 2002 Oct;59(10):1565-71 - PubMed
    1. Brain. 1999 Mar;122 ( Pt 3):513-21 - PubMed

Publication types

MeSH terms

LinkOut - more resources